|
|
Pfizer in Talks to Buy Global Blood Therapeutics for $5 Billion, Report Says
By Josh Nathan-KazisFollow
Aug. 5, 2022 12:08 pm ET
Order Reprints
Print Article
Pfizer PFE –0.73% is in late-stage negotiations to buy the drug maker Global Blood Therapeutics GBT +38.57% for $5 billion, though other companies are also continuing to make bids, The Wall Street Journal reported Friday.
Shares of Global Blood Therapeutics (ticker: GBT), which sells a treatment for sickle cell disease called Oxbryta, climbed 41.4% on Thursday after Bloomberg reported Wednesday that “large pharmaceutical companies” were looking into a potential acquisition of the firm. |
|
狗仔卡
发表于 2022-8-5 11:41 AM
提升卡
置顶卡
沉默卡
喧嚣卡
变色卡